Pharmacovigilance: the least understood and least practiced science in dentistry

Chaya Chhabra, Kumar G. Chhabra, Ashish Sharma, Akanksha Goyal, Gururaghavendran Rajesh, Almas Binnal

Research output: Contribution to journalReview article

Abstract

Aim: The purpose of this review was to explore the overall scenario of pharmacovigilance, its aims, challenges, and recommendations pertaining to dentistry for further improvements. Materials and methods: Literature search was done with the help of the Endnote software, followed by vigilantly arranging the material in a coordinated way. Results: Adverse drug reactions (ADRs) are among the top 10 leading causes of all-cause mortality. In order to reduce the harm to the patients and serve the public health mission, there is a definite need for developing mechanisms for evaluating and monitoring the safety of medicines in India. Therefore, the requirement for developing a well-organized pharmacovigilance system is imperative. Different countries have developed their own reporting guidelines for pharmacovigilance. The reporting guidelines are conceived to adapt to the specific requirements of any country and the prime focus of these adverse event reporting systems is improving the patient’s health and safety. The Central Drugs Standard Control Organization (CDSCO) has initiated a nation-wide pharmacovigilance program in India. It aims to protect the health of the patients by assuring drug safety under the aegis of Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. In dentistry, the science of pharmacovigilance is rarely applied and its practice among dental health professionals, including reporting of ADRs, is minimal. However, studies have shown that the dental professionals comprehend the importance of pharmacovigilance and its application in dentistry. Conclusion: It is essential to foster a sense of trust among patients regarding the medicines they use, to ensure that risks in drug use are anticipated and managed. This will eventually enhance the confidence of patients on the healthcare delivery system in general. Clinical significance: The practice of dentistry involves prescribing various medications for patient use. It is therefore the duty of the dentist to comprehend and identify the adverse effects of the drugs. Dentists should also know about the right channel for reporting any instances of ADRs. They should also strive toward increasing the awareness among patients regarding possible side effects so that any untoward consequences can be avoided. This will be an invaluable aid in furthering the public health mission of improving the health of the populations.

Original languageEnglish
Pages (from-to)402-406
Number of pages5
JournalWorld Journal of Dentistry
Volume10
Issue number5
DOIs
Publication statusPublished - 01-09-2019

Fingerprint

Pharmacovigilance
Dentistry
Drug-Related Side Effects and Adverse Reactions
India
Health
Dentists
Tooth
Public Health
Pharmaceutical Preparations
Guidelines
Patient Harm
Delivery of Health Care
Safety
Family Health
Drug and Narcotic Control
Patient Safety
Developed Countries
Health Services
Software
Organizations

All Science Journal Classification (ASJC) codes

  • Dentistry(all)

Cite this

Chhabra, Chaya ; Chhabra, Kumar G. ; Sharma, Ashish ; Goyal, Akanksha ; Rajesh, Gururaghavendran ; Binnal, Almas. / Pharmacovigilance : the least understood and least practiced science in dentistry. In: World Journal of Dentistry. 2019 ; Vol. 10, No. 5. pp. 402-406.
@article{b2161af66a4848c6a2047c791b8de04a,
title = "Pharmacovigilance: the least understood and least practiced science in dentistry",
abstract = "Aim: The purpose of this review was to explore the overall scenario of pharmacovigilance, its aims, challenges, and recommendations pertaining to dentistry for further improvements. Materials and methods: Literature search was done with the help of the Endnote software, followed by vigilantly arranging the material in a coordinated way. Results: Adverse drug reactions (ADRs) are among the top 10 leading causes of all-cause mortality. In order to reduce the harm to the patients and serve the public health mission, there is a definite need for developing mechanisms for evaluating and monitoring the safety of medicines in India. Therefore, the requirement for developing a well-organized pharmacovigilance system is imperative. Different countries have developed their own reporting guidelines for pharmacovigilance. The reporting guidelines are conceived to adapt to the specific requirements of any country and the prime focus of these adverse event reporting systems is improving the patient’s health and safety. The Central Drugs Standard Control Organization (CDSCO) has initiated a nation-wide pharmacovigilance program in India. It aims to protect the health of the patients by assuring drug safety under the aegis of Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. In dentistry, the science of pharmacovigilance is rarely applied and its practice among dental health professionals, including reporting of ADRs, is minimal. However, studies have shown that the dental professionals comprehend the importance of pharmacovigilance and its application in dentistry. Conclusion: It is essential to foster a sense of trust among patients regarding the medicines they use, to ensure that risks in drug use are anticipated and managed. This will eventually enhance the confidence of patients on the healthcare delivery system in general. Clinical significance: The practice of dentistry involves prescribing various medications for patient use. It is therefore the duty of the dentist to comprehend and identify the adverse effects of the drugs. Dentists should also know about the right channel for reporting any instances of ADRs. They should also strive toward increasing the awareness among patients regarding possible side effects so that any untoward consequences can be avoided. This will be an invaluable aid in furthering the public health mission of improving the health of the populations.",
author = "Chaya Chhabra and Chhabra, {Kumar G.} and Ashish Sharma and Akanksha Goyal and Gururaghavendran Rajesh and Almas Binnal",
year = "2019",
month = "9",
day = "1",
doi = "10.5005/jp-journals-10015-1661",
language = "English",
volume = "10",
pages = "402--406",
journal = "World Journal of Dentistry",
issn = "0976-6006",
publisher = "Jaypee Brothers Medical Publishers (P) Ltd",
number = "5",

}

Pharmacovigilance : the least understood and least practiced science in dentistry. / Chhabra, Chaya; Chhabra, Kumar G.; Sharma, Ashish; Goyal, Akanksha; Rajesh, Gururaghavendran; Binnal, Almas.

In: World Journal of Dentistry, Vol. 10, No. 5, 01.09.2019, p. 402-406.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pharmacovigilance

T2 - the least understood and least practiced science in dentistry

AU - Chhabra, Chaya

AU - Chhabra, Kumar G.

AU - Sharma, Ashish

AU - Goyal, Akanksha

AU - Rajesh, Gururaghavendran

AU - Binnal, Almas

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Aim: The purpose of this review was to explore the overall scenario of pharmacovigilance, its aims, challenges, and recommendations pertaining to dentistry for further improvements. Materials and methods: Literature search was done with the help of the Endnote software, followed by vigilantly arranging the material in a coordinated way. Results: Adverse drug reactions (ADRs) are among the top 10 leading causes of all-cause mortality. In order to reduce the harm to the patients and serve the public health mission, there is a definite need for developing mechanisms for evaluating and monitoring the safety of medicines in India. Therefore, the requirement for developing a well-organized pharmacovigilance system is imperative. Different countries have developed their own reporting guidelines for pharmacovigilance. The reporting guidelines are conceived to adapt to the specific requirements of any country and the prime focus of these adverse event reporting systems is improving the patient’s health and safety. The Central Drugs Standard Control Organization (CDSCO) has initiated a nation-wide pharmacovigilance program in India. It aims to protect the health of the patients by assuring drug safety under the aegis of Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. In dentistry, the science of pharmacovigilance is rarely applied and its practice among dental health professionals, including reporting of ADRs, is minimal. However, studies have shown that the dental professionals comprehend the importance of pharmacovigilance and its application in dentistry. Conclusion: It is essential to foster a sense of trust among patients regarding the medicines they use, to ensure that risks in drug use are anticipated and managed. This will eventually enhance the confidence of patients on the healthcare delivery system in general. Clinical significance: The practice of dentistry involves prescribing various medications for patient use. It is therefore the duty of the dentist to comprehend and identify the adverse effects of the drugs. Dentists should also know about the right channel for reporting any instances of ADRs. They should also strive toward increasing the awareness among patients regarding possible side effects so that any untoward consequences can be avoided. This will be an invaluable aid in furthering the public health mission of improving the health of the populations.

AB - Aim: The purpose of this review was to explore the overall scenario of pharmacovigilance, its aims, challenges, and recommendations pertaining to dentistry for further improvements. Materials and methods: Literature search was done with the help of the Endnote software, followed by vigilantly arranging the material in a coordinated way. Results: Adverse drug reactions (ADRs) are among the top 10 leading causes of all-cause mortality. In order to reduce the harm to the patients and serve the public health mission, there is a definite need for developing mechanisms for evaluating and monitoring the safety of medicines in India. Therefore, the requirement for developing a well-organized pharmacovigilance system is imperative. Different countries have developed their own reporting guidelines for pharmacovigilance. The reporting guidelines are conceived to adapt to the specific requirements of any country and the prime focus of these adverse event reporting systems is improving the patient’s health and safety. The Central Drugs Standard Control Organization (CDSCO) has initiated a nation-wide pharmacovigilance program in India. It aims to protect the health of the patients by assuring drug safety under the aegis of Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. In dentistry, the science of pharmacovigilance is rarely applied and its practice among dental health professionals, including reporting of ADRs, is minimal. However, studies have shown that the dental professionals comprehend the importance of pharmacovigilance and its application in dentistry. Conclusion: It is essential to foster a sense of trust among patients regarding the medicines they use, to ensure that risks in drug use are anticipated and managed. This will eventually enhance the confidence of patients on the healthcare delivery system in general. Clinical significance: The practice of dentistry involves prescribing various medications for patient use. It is therefore the duty of the dentist to comprehend and identify the adverse effects of the drugs. Dentists should also know about the right channel for reporting any instances of ADRs. They should also strive toward increasing the awareness among patients regarding possible side effects so that any untoward consequences can be avoided. This will be an invaluable aid in furthering the public health mission of improving the health of the populations.

UR - http://www.scopus.com/inward/record.url?scp=85078232857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078232857&partnerID=8YFLogxK

U2 - 10.5005/jp-journals-10015-1661

DO - 10.5005/jp-journals-10015-1661

M3 - Review article

AN - SCOPUS:85078232857

VL - 10

SP - 402

EP - 406

JO - World Journal of Dentistry

JF - World Journal of Dentistry

SN - 0976-6006

IS - 5

ER -